Adjuvante radio- und chemotherapie beim zervixkarzinom

Translated title of the contribution: Adjuvant pelvic radiation and chemotherapy for cervical cancer

G. Häinsgen*, J. Dunst

*Corresponding author for this work
9 Citations (Scopus)


The screening for cervical cancer has been reduced both the incidence of and mortality from invasive cervical cancer in the western world. Radical pelvic surgery is an effective treatment for early invasive cervical cancer (FIGO-stage I B and II A), but for woman with more advanced disease radiotherapy is the standard treatment. However, the survival of the cervical cancer patients has not been improved over the last decade. Previous studies have suggested that chemotherapy and radiotherapy are synergistic. The results of five large studies have shown that cisplatin-based chemotherapy when given at the same time a radiation therapy, prolongs survival in woman with cervical cancer. This was also observed in primary treatment schedule as in adjuvant situation. The side effects were temporary and manageable. The results suggest that chemoradiation is the favorable therapy for cervical cancer in advanced stage and in high-risk-situation.

Translated title of the contributionAdjuvant pelvic radiation and chemotherapy for cervical cancer
Original languageGerman
JournalZentralblatt fur Gynakologie
Issue number5
Pages (from-to)280-285
Number of pages6
Publication statusPublished - 2001


Dive into the research topics of 'Adjuvant pelvic radiation and chemotherapy for cervical cancer'. Together they form a unique fingerprint.

Cite this